Latest profit margin for Claritev: -28.46% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Claritev (CTEV) currently reports a profit margin of -28.46% as of June 2026. That compares with -70.91% in the prior-year period — up 59.9% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore Claritev's profit margin history and peer comparisons.
Claritev's profit margin increased from -70.91% to -28.46% — a 59.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Claritev's profit margin of -28.46% is lower than the Healthcare sector average of 14.41%. That is roughly 297.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Claritev's current -28.46% should be judged against Healthcare norms (sector average: 14.41%) and against CTEV's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -28.46%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for Claritev, and consider following CTEV for alerts when major investors trade the stock.